Should Everyone be on GLP-1s?

Should Everyone be on GLP-1s?

Up next

Food Politics, Obesity, and the "Wicked Mess" We're In

The United States has witnessed a staggering rise in obesity beginning in the early 1980s, leading to a wide array of important health consequences including heart disease, diabetes, and premature death. In this episode of Healthy Dialogue, Host Derek C. Angus, MD, MPH, talks wit ...  Show more

Why and How Should the Government Fund Biomedical Research?

This episode of Healthy Dialogue explores the history and future of science funding in the US in light of recent changes, and proposed changes, from the federal government. Host Derek Angus, MD, MPH, speaks with former editor in chief of Science and a former director of the Natio ...  Show more

Recommended Episodes

Randomized Trial of Anti-VEGF to Prevent Proliferative Diabetic Retinopathy (PDR) and Diabetic Macular Edema (DME)
JAMA Ophthalmology Author Interviews

Interview with Raj K Maturi, MD, and Jennifer K Sun, MD, authors of Effect of Intravitreous Anti–Vascular Endothelial Growth Factor vs Sham Treatment for Prevention of Vision-Threatening Complications of Diabetic Retinopathy: The Protocol W Randomized Clinical Trial and with Howa ...  Show more

November 2021: Issue Summary 1
Radiology Podcast | RSNA

Dr. Lauren Kim interviews Dr. Florian Gassert and Dr. Theresa Urban. X-ray Dark-Field Chest Imaging: Qualitative and Quantitative Results in Healthy Humans. Gassert and Urban et al. Radiology 2021; 301:389–395. Introduction by Dr. Linda Chu 

USPSTF Recommendation: Interventions for High BMI in Children and Adolescents
JAMA Clinical Reviews

Interview with John M. Ruiz, PhD, USPSTF member and coauthor of Management of BMI in Children: US Preventive Services Task Force Recommendation Statement. Hosted by JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS.

Related Content:

< ...  Show more

Time to Significant Benefit of Finerenone in Patients with Heart Failure | HFSA 2024
JACC This Week

Michelle M Kittleson, MD, FACC, JACC Associate Editor, speaks with author Muthiah Vaduganathan, MD on his accepted paper concerning the FINEARTS trial published in JACC.